Kuhar MJ - Search Results

1

Selective dopamine transporter inhibition by cocaine analogs.

Boja JW, McNeill RM, Lewin AH, Abraham P, Carroll FI, Kuhar MJ. Boja JW, et al. Among authors: kuhar mj. Neuroreport. 1992 Nov;3(11):984-6. doi: 10.1097/00001756-199211000-00009. Neuroreport. 1992. PMID: 1482769

2

Recovery of dopamine transporter binding and function after intrastriatal administration of the irreversible inhibitor RTI-76 [3 beta-(3p-chlorophenyl) tropan-2 beta-carboxylic acid p-isothiocyanatophenylethyl ester hydrochloride].

Fleckenstein AE, Pögün S, Carroll FI, Kuhar MJ. Fleckenstein AE, et al. Among authors: kuhar mj. J Pharmacol Exp Ther. 1996 Oct;279(1):200-6. J Pharmacol Exp Ther. 1996. PMID: 8858994

3

Highly potent cocaine analogs cause long-lasting increases in locomotor activity.

Fleckenstein AE, Kopajtic TA, Boja JW, Carroll FI, Kuhar MJ. Fleckenstein AE, et al. Among authors: kuhar mj. Eur J Pharmacol. 1996 Sep 12;311(2-3):109-14. doi: 10.1016/0014-2999(96)00423-2. Eur J Pharmacol. 1996. PMID: 8891589

4

N-substituted phenyltropanes as in vivo binding ligands for rapid imaging studies of the dopamine transporter.

Scheffel U, Lever JR, Abraham P, Parham KR, Mathews WB, Kopajtic T, Carroll FI, Kuhar MJ. Scheffel U, et al. Among authors: kuhar mj. Synapse. 1997 Apr;25(4):345-9. doi: 10.1002/(SICI)1098-2396(199704)25:4<345::AID-SYN5>3.0.CO;2-A. Synapse. 1997. PMID: 9097393

5

Multiple binding sites for [125I]RTI-121 and other cocaine analogs in rat frontal cerebral cortex.

Boja JW, Carroll FI, Vaughan RA, Kopajtic T, Kuhar MJ. Boja JW, et al. Among authors: kuhar mj. Synapse. 1998 Sep;30(1):9-17. doi: 10.1002/(SICI)1098-2396(199809)30:1<9::AID-SYN2>3.0.CO;2-7. Synapse. 1998. PMID: 9704876

6

A cocaine analog and a GBR analog label the same protein in rat striatal membranes.

Patel A, Boja JW, Lever J, Lew R, Simantov R, Carroll FI, Lewin AH, Philip A, Gao Y, Kuhar MJ. Patel A, et al. Among authors: kuhar mj. Brain Res. 1992 Mar 27;576(1):173-4. doi: 10.1016/0006-8993(92)90627-l. Brain Res. 1992. PMID: 1515909

7

Behavioral effects of novel cocaine analogs: a comparison with in vivo receptor binding potency.

Cline EJ, Scheffel U, Boja JW, Carroll FI, Katz JL, Kuhar MJ. Cline EJ, et al. Among authors: kuhar mj. J Pharmacol Exp Ther. 1992 Mar;260(3):1174-9. J Pharmacol Exp Ther. 1992. PMID: 1545384

8

Probes for the cocaine receptor. Potentially irreversible ligands for the dopamine transporter.

Carroll FI, Gao Y, Abraham P, Lewin AH, Lew R, Patel A, Boja JW, Kuhar MJ. Carroll FI, et al. Among authors: kuhar mj. J Med Chem. 1992 May 15;35(10):1813-7. doi: 10.1021/jm00088a017. J Med Chem. 1992. PMID: 1588560

9

High potency cocaine analogs: neurochemical, imaging, and behavioral studies.

Boja JW, Cline EJ, Carroll FI, Lewin AH, Philip A, Dannals R, Wong D, Scheffel U, Kuhar MJ. Boja JW, et al. Among authors: kuhar mj. Ann N Y Acad Sci. 1992 Jun 28;654:282-91. doi: 10.1111/j.1749-6632.1992.tb25974.x. Ann N Y Acad Sci. 1992. PMID: 1632587 Review. No abstract available.

10

The dopamine hypothesis of the reinforcing properties of cocaine.

Kuhar MJ, Ritz MC, Boja JW. Kuhar MJ, et al. Trends Neurosci. 1991 Jul;14(7):299-302. doi: 10.1016/0166-2236(91)90141-g. Trends Neurosci. 1991. PMID: 1719677 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

467 results

Search Page

Filters